Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果